Tags: fda | approves | hepc | drug

FDA Approves Breakthrough Hepatitis C Drug

Friday, 06 Dec 2013 05:40 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink
U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a treatment for chronic infection with the liver-destroying hepatitis C virus.

The pill is the first approved to treat certain types of hepatitis C infection without the need for interferon, an injected drug that can cause severe flu-like symptoms.

Hepatitis C, which is often undiagnosed, affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer.

Gilead said Sovaldi can be used in combination with ribavirin, an older antiviral pill, for patients with genotypes 2 and 3 infections, which account for about 28 percent of U.S. patients infected with the virus.

For patients with genotypes 1 or 4, the new drug needs to be used with both interferon and ribavirin, although it can be considered for use in patients with genotype 1 infections who cannot use interferon.

Gilead has estimated that around 70 percent of U.S. patients have genotype 1 hepatitis C infections.

The drug's approval was supported by several studies showing that it helped to eradicate the virus in significantly more patients, with fewer side effects, than the current drug regimen.

Sovaldi is the first in a new class of medications known as nucleotide analogue inhibitors, or "nukes," designed to block a specific protein that the hepatitis C virus needs to copy itself.

Analysts, on average, have forecast Sovaldi sales of $1.9 billion next year, according to BMO Capital Markets.

Shares of Gilead, which have nearly doubled over the past 12 months, were little changed in after-hours trading. The shares rose 1 percent to close at $73.99 in regular Nasdaq trading on Friday.

 

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

US Crude Plunges 10% in Biggest One-Day Drop Since 2009

Friday, 28 Nov 2014 21:41 PM

U.S. crude tumbled 10 percent in its biggest one-day drop in more than five years on Friday, and benchmark Brent broke b . . .

National Protests Over Ferguson Briefly Close Malls, Shut Down Trains

Friday, 28 Nov 2014 21:20 PM

Demonstrators temporarily shut down two large malls in suburban St. Louis on one of the busiest shopping days of the yea . . .

Next Partisan 'War' in New Congress Will Be Over Science

Friday, 28 Nov 2014 19:58 PM

After midterm battles, an immigration standoff and amid a switch of power in Congress, the next political fight in Washi . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved